• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽瓜氨酸脱氨酶4:类风湿性关节炎的病理生理学、当前治疗方法及未来展望

PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.

作者信息

Koushik Sindhu, Joshi Nivedita, Nagaraju Shruthi, Mahmood Sameer, Mudeenahally Krishna, Padmavathy Ramya, Jegatheesan Sooriya Kumar, Mullangi Ramesh, Rajagopal Sriram

机构信息

a Bioinformatics , Jubilant Biosys Ltd ., Bangalore , India.

出版信息

Expert Opin Ther Targets. 2017 Apr;21(4):433-447. doi: 10.1080/14728222.2017.1294160. Epub 2017 Feb 22.

DOI:10.1080/14728222.2017.1294160
PMID:28281906
Abstract

Peptidyl arginine deiminase 4 (PAD4) is an enzyme that plays an important role in gene expression, turning out genetic code into functional products in the body. It is involved in a key post translational modification, which involves the conversion of arginine to citrulline. It regulates various processes such as apoptosis, innate immunity and pluripotency, while its dysregulation has a great impact on the genesis of various diseases. Over the last few years PAD4 has emerged as a potential therapeutic target for the treatment of rheumatoid arthritis (RA). Areas covered: In this review, we discuss the basic structure and function of PAD4, along with the role of altered PAD4 activity in the onset of RA and other maladies. We also elucidate the role of PAD4 variants in etiology of RA among several ethnic groups and the current pre-clinical inhibitors to regulate PAD4. Expert opinion: Citrullination has a crucial role in RA and several other disorders. Since PAD4 is an initiator of the citrullination, it is an important therapeutic target for inflammatory diseases. Therefore, an in depth knowledge of the roles and activity of PAD4 is required to explore more effective ways to conquer PAD4 related ailments, especially RA.

摘要

肽基精氨酸脱亚氨酶4(PAD4)是一种在基因表达中起重要作用的酶,它能将遗传密码转化为体内的功能产物。它参与一种关键的翻译后修饰,即精氨酸向瓜氨酸的转化。它调节多种过程,如细胞凋亡、先天免疫和多能性,而其失调对各种疾病的发生有很大影响。在过去几年中,PAD4已成为治疗类风湿性关节炎(RA)的潜在治疗靶点。涵盖领域:在本综述中,我们讨论了PAD4的基本结构和功能,以及PAD4活性改变在RA和其他疾病发病中的作用。我们还阐明了PAD4变体在几个种族群体RA病因中的作用以及目前调节PAD4的临床前抑制剂。专家意见:瓜氨酸化在RA和其他几种疾病中起关键作用。由于PAD4是瓜氨酸化的启动者,它是炎症性疾病的重要治疗靶点。因此,需要深入了解PAD4的作用和活性,以探索更有效的方法来攻克与PAD4相关的疾病,尤其是RA。

相似文献

1
PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.肽瓜氨酸脱氨酶4:类风湿性关节炎的病理生理学、当前治疗方法及未来展望
Expert Opin Ther Targets. 2017 Apr;21(4):433-447. doi: 10.1080/14728222.2017.1294160. Epub 2017 Feb 22.
2
Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.新型潜在可逆转肽基精氨酸脱亚氨酶抑制剂的发现。
Int J Mol Sci. 2019 May 2;20(9):2174. doi: 10.3390/ijms20092174.
3
Peptidylarginine deiminase-4: Medico-formulative strategy towards management of rheumatoid arthritis.肽基精氨酸脱亚氨酶4:类风湿性关节炎治疗的医学配方策略
Biochem Pharmacol. 2022 Jun;200:115040. doi: 10.1016/j.bcp.2022.115040. Epub 2022 Apr 15.
4
Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential.蛋白精氨酸脱亚氨酶4(PAD4):当前的认识与未来的治疗潜力
Curr Opin Drug Discov Devel. 2009 Sep;12(5):616-27.
5
Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.肿瘤坏死因子α诱导的瓜氨酸化和关节炎需要肽基精氨酸脱亚氨酶2,但中性粒细胞胞外陷阱形成不需要。
J Autoimmun. 2017 Jun;80:39-47. doi: 10.1016/j.jaut.2017.01.006. Epub 2017 Feb 7.
6
Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.类风湿关节炎中抗肽基精氨酸脱亚氨酶 4 型(抗-PAD4)自身抗体的临床和免疫学方面。
Autoimmun Rev. 2018 Feb;17(2):94-102. doi: 10.1016/j.autrev.2017.11.023. Epub 2017 Dec 2.
7
Revamped role for approved drug: integrative computational and biophysical analysis of saquinavir's peptidyl arginine deiminase 4 inhibition for rheumatoid arthritis.已批准药物的新作用:对沙奎那韦的肽基精氨酸脱亚氨酶 4 抑制类风湿关节炎的综合计算和生物物理分析。
Biochem J. 2024 Oct 16;481(20):1379-1393. doi: 10.1042/BCJ20240366.
8
Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.蛋白精氨酸脱亚氨酶(PADs):蛋白质瓜氨酸化的生化和化学生物学。
Acc Chem Res. 2019 Mar 19;52(3):818-832. doi: 10.1021/acs.accounts.9b00024. Epub 2019 Mar 7.
9
Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.蛋白质精氨酸脱亚氨酶4的抑制剂和失活剂:功能与结构表征
Biochemistry. 2006 Oct 3;45(39):11727-36. doi: 10.1021/bi061180d.
10
Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening.基于结构的虚拟筛选发现新型的蛋白质精氨酸脱亚氨酶 4(PAD4)抑制剂。
BMC Bioinformatics. 2012;13 Suppl 17(Suppl 17):S4. doi: 10.1186/1471-2105-13-S17-S4. Epub 2012 Dec 13.

引用本文的文献

1
Computer-aided repositioning and functional assessment of novel PAD4 inhibitors.新型PAD4抑制剂的计算机辅助重新定位及功能评估
RSC Med Chem. 2025 Jun 30. doi: 10.1039/d5md00395d.
2
A Multifaceted Computational Approach to Identify PAD4 Inhibitors for the Treatment of Rheumatoid Arthritis (RA).一种用于识别治疗类风湿性关节炎(RA)的蛋白酶3(PAD4)抑制剂的多方面计算方法。
Metabolites. 2025 Feb 25;15(3):156. doi: 10.3390/metabo15030156.
3
Colchicine prevents perioperative myocardial injury in cardiac surgery by inhibiting the formation of neutrophil extracellular traps: evidence from rat models.
秋水仙碱通过抑制中性粒细胞胞外诱捕网的形成预防心脏手术围术期心肌损伤:来自大鼠模型的证据。
Eur J Cardiothorac Surg. 2024 Oct 1;66(4). doi: 10.1093/ejcts/ezae364.
4
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases.跨越表观遗传学前沿:新型组蛋白修饰与疾病的交汇点。
Signal Transduct Target Ther. 2024 Sep 16;9(1):232. doi: 10.1038/s41392-024-01918-w.
5
The role of anti-citrullinated protein antibody in pathogenesis of RA.抗瓜氨酸化蛋白抗体在类风湿关节炎发病机制中的作用。
Clin Exp Med. 2024 Jul 8;24(1):153. doi: 10.1007/s10238-024-01359-3.
6
Antibody discovery identifies regulatory mechanisms of protein arginine deiminase 4.抗体发现鉴定了蛋白质精氨酸脱亚氨酶 4 的调控机制。
Nat Chem Biol. 2024 Jun;20(6):742-750. doi: 10.1038/s41589-023-01535-8. Epub 2024 Feb 2.
7
Multiple Sclerosis: New Insights into Molecular Pathogenesis and Novel Platforms for Disease Treatment.多发性硬化症:分子发病机制的新见解和疾病治疗的新平台。
Curr Drug Res Rev. 2024;16(2):175-197. doi: 10.2174/2589977516666230915103730.
8
Inhibition of protein arginine deiminase 4 prevents inflammation-mediated heart failure in arthritis.抑制蛋白质精氨酸脱亚氨酶 4 可预防关节炎炎症介导的心力衰竭。
Life Sci Alliance. 2023 Jul 27;6(10). doi: 10.26508/lsa.202302055. Print 2023 Oct.
9
Potential peptidyl arginine deiminase type 4 inhibitors from : a structure-based drug design approach.基于结构的药物设计方法筛选潜在的4型肽基精氨酸脱亚氨酶抑制剂
In Silico Pharmacol. 2023 May 2;11(1):13. doi: 10.1007/s40203-023-00147-3. eCollection 2023.
10
Sinomenine ameliorates adjuvant-induced arthritis by inhibiting the autophagy/NETosis/inflammation axis.青藤碱通过抑制自噬/NETosis/炎症轴缓解佐剂性关节炎。
Sci Rep. 2023 Mar 9;13(1):3933. doi: 10.1038/s41598-023-30922-3.